Before enrolling with MANÜ Telehealth, the most useful question is not simply what a GLP-1 prescription costs. It is what transaction you are authorizing, with which business, and what happens if treatment does not proceed. MANÜ advertises virtual weight-loss care, medication packages and free shipping. Its public documentation also separates a healthcare practice, technology platform, independent clinicians and dispensing pharmacies—while describing some of those roles inconsistently.
This review examines the public pages consulted October 19, 2026, with particular attention to enrollment, recurring billing and exit rights. There are meaningful disclosures: prescriptions are not guaranteed, general subscription cancellation is available by email, and company-canceled paid orders qualify for a full refund. However, conflicting state-availability statements and incomplete medication pricing prevent a clean account of the agreement a prospective patient would actually enter. Those gaps deserve written answers before payment, not assumptions based on the advertising.
At a glance
- Documented GLP-1 offerings
- MANÜ advertises compounded injectable semaglutide and compounded injectable tirzepatide, not FDA-approved versions of those preparations.
- Incomplete starting prices
- Different homepage blocks advertise GLP-1s from $4 per day and from $5 per day without establishing the product, supply duration or full billing obligation.Sources: [7]
- General subscription cancellation
- The terms allow cancellation through info@manutelehealth.com, generally effective at the end of the current billing cycle, without partial-period refunds unless legally required.Sources: [11]
- Geographic contradiction
- The homepage advertises coverage in all 50 states, subject to confirmation; the privacy policy says services are available only to Florida residents.
- Practice and platform
- The legal center identifies Ziggy Telehealth LLC as the practice shown as MANÜ Telehealth, and Medoura, operated by CoFabri LLC, as the technology platform.Sources: [8]
Establish who is making the agreement
MANÜ’s enrollment form states that the platform supplies technology only and that healthcare services come from Ziggy Telehealth LLC. The legal center likewise identifies Ziggy as “Your Healthcare Practice,” shown to patients as MANÜ Telehealth. Separately, it identifies Medoura as a technology platform owned and operated by CoFabri LLC. Medoura expressly says it is not a healthcare provider, medical practice, pharmacy, laboratory or emergency service.
The general terms create a complication: they say MANÜ Telehealth is not a licensed medical provider and does not practice medicine, instead facilitating connections with independent licensed healthcare professionals. That is not a fully consistent description of the branded practice identified elsewhere. The documents establish several participants, but do not resolve every boundary between the public-facing brand, clinical practice and facilitator. A patient should request the legal name of the treating practice and the merchant taking payment.
These distinctions affect where a complaint or request belongs. The legal center directs billing, refund, subscription, pharmacy and shipment questions to the responsible practice, merchant, pharmacy or other provider identified in the workflow or receipt. Before paying, retain those identities and contact details rather than relying on the brand name alone. Our guide to mapping platform, clinician and pharmacy responsibilities explains why that separation matters when one enrollment involves several businesses.
| Participant | Documented role | Point to clarify |
|---|---|---|
| Ziggy Telehealth LLC | Healthcare practice shown as MANÜ Telehealth | Which practice accepts responsibility for your care? |
| MANÜ Telehealth | Brand; general terms also describe a facilitator | Which legal entity is contracting and charging you? |
| Medoura / CoFabri LLC | Technology platform, not a healthcare provider or pharmacy | Where should platform-access problems be sent? |
| Treating clinician | Independent clinical decisions and prescription discretion | Who accepts you as a patient and handles follow-up? |
| Dispensing pharmacy | Prescription fulfillment and shipment | Which pharmacy will fill your particular order? |
Resolve state eligibility before completing enrollment
The most consequential enrollment conflict concerns geography. MANÜ’s homepage says it currently has licensed providers and pharmacy coverage in all 50 states. It adds that coverage can change as the network and pharmacy licensing evolve, and tells applicants to enter their address for confirmation. That qualification makes the national statement conditional, rather than a promise that every applicant can receive every advertised service.
The privacy policy is materially narrower. It says services are not currently available outside Florida and instructs non-Florida residents not to access or use them. It also states that the service does not currently comply with state privacy and security laws outside Florida. The consulted documentation does not reconcile this language with the nationwide homepage claim. Neither statement should silently be treated as overriding the other; prospective patients need an explicit, state-specific explanation.
The same policy excludes individuals located outside the United States and residents of other countries. General terms require users to be at least 18 and provide accurate, current and complete information. Both GLP-1 product pages describe adults with BMI of at least 30, or at least 27 with weight-related conditions. Those published thresholds are not approval guarantees. For a non-Florida applicant especially, confirming service availability should come before treating the intake as an invitation to proceed.
Separate the free assessment from a clinical commitment
The intake begins by requesting an email address and phone number, allowing applicants to start or resume an application. It advertises a free assessment taking less than five minutes, with “nothing charged.” That describes the initial questionnaire, not the time required for clinical review, prescribing or delivery. The advertised process asks about health goals and medical history, followed by review by professionals the site describes as licensed healthcare providers.
A product page says that, if approved, a board-certified physician will prescribe, with no in-person visit required. Meanwhile, the team page lists Cristina, Nadja and Richard as nurse practitioners and Selvia as a family nurse practitioner. Those are different professional descriptions, not interchangeable titles. The pages do not establish who would see a particular applicant, and this review did not independently verify the listed credentials, certifications or state assignments.
The legal terms provide the clearest limit on enrollment: a provider-patient relationship forms only when the provider explicitly accepts the person for treatment. Clinical decisions, including whether to prescribe, remain with that provider and are not guaranteed. Before authorizing a paid step, ask when acceptance occurs, what service the payment buys and what happens financially if prescribing is declined. The free opening assessment alone does not answer those later transaction questions.
Obtain a full charge schedule, not a daily-price impression
MANÜ’s homepage displays two different starting-price claims: GLP-1s “from $4/day” and “from $5/day,” each alongside free-shipping language. The consulted pages do not explain the difference or identify the exact medication, supply duration, presentation or commitment supporting either figure. These are partial advertised starting prices, not established monthly bills. Converting them into a presumed calendar-month charge would create a number the documentation does not actually quote.
The FAQ says each medication package includes the online consultation, medication, supplies and shipping. That is useful scope information, but it does not establish a complete semaglutide or tirzepatide price or resolve whether every possible clinical service is included. The terms say certain services use recurring billing, with the applicable fee and frequency stated at purchase. They also permit subscription-price changes with advance notice and treat continued subscription use after the effective date as acceptance.
Request a written GLP-1 quote identifying the compounded injectable product, amount supplied, first charge, subsequent charges, billing interval and included services. The reviewed documentation does not establish specific prepayment plans, insurance acceptance, prior-authorization assistance or HSA/FSA use. It also leaves laboratory requirements and costs undefined. Those gaps do not prove such options or charges exist; they mean the public advertising is insufficient to determine the complete financial commitment.
Read cancellation and refunds as different rights
For general subscriptions, the terms allow cancellation at any time by contacting info@manutelehealth.com. Cancellation ordinarily takes effect at the end of the current billing cycle unless otherwise specified. The same clause denies refunds for partial billing periods unless applicable law requires them. In practical terms, permission to cancel is not a promise to reverse an existing charge, reimburse unused time or interrupt an order already progressing through fulfillment.
The broader refund language says all sales are final except for company-initiated cancellation as described in the terms or where law requires otherwise. MANÜ says it is generally unable to offer refunds after services have been rendered or medications dispensed because the transaction involves clinical review, fulfillment and third-party providers. If MANÜ cancels an already-paid order, however, the terms promise a full refund to the original payment method and reasonable efforts to notify the customer.
The documents do not establish a refund-arrival timetable or a clear financial outcome for every possible declined-prescription scenario. Before purchase, ask how clinical review, provider rejection, patient cancellation and pharmacy dispensing each affect the charge. Keep the cancellation request and any acknowledgment. Our explanation of refund boundaries and exclusions is useful here: an advertised ability to stop a subscription and an entitlement to recover money address different stages of a transaction.
Keep nutrition-store deadlines and add-ons in their own lane
MANÜ’s terms contain separate nutrition-store provisions. For those transactions, the nutrition section takes precedence over conflicting general rules on orders, subscriptions and refunds. A nutrition-store subscriber must contact the company at least 48 hours before the next scheduled renewal to prevent that renewal from being charged. Requests received within that window may not be processed in time to prevent the cycle’s charge and shipment.
That deadline should not automatically be applied to clinical GLP-1 subscriptions: its documented scope is the nutrition store. Conversely, a nutrition-store customer should not assume that the general cancel-at-any-time wording guarantees prevention of an imminent charge. Before combining purchases, identify which rules govern each line item. The practical distinction is covered in our guide to cancellation notice and renewal dates, particularly when a cancellation request and fulfillment activity overlap.
The wider catalog includes NAD+, sermorelin, glutathione and Bliss Tabs. MANÜ also markets MIC Ultraburn, an injectable methionine, inositol and choline blend, as an add-on to GLP-1 treatment. Its plan block starts at $150 without specifying a supply period or billing frequency. The claimed metabolism and energy benefits are the provider’s marketing, not findings established here. Promotional codes likewise have individual restrictions, may apply only to certain products or services, and may expire without notice.
Identify the pharmacy and the delivery remedy
MANÜ says it is not an internet pharmacy and does not dispense, ship or distribute medication from its own facility or website. Its disclosure says prescribed medication is dispensed exclusively through a U.S. 503A pharmacy. The privacy policy names Boudreaux, Shields Pharmacy and Hallandale as pharmacies that prepare and ship prescriptions. Those names do not identify which pharmacy will handle an individual order, and their licenses were not independently verified for this review.
The advertised process promises direct-to-door fulfillment with free, discreet packaging. It does not establish clinical-review, pharmacy-preparation or arrival deadlines, nor a documented replacement procedure for damaged clinical shipments. The product page describes compounded medication as prepared by a licensed compounding pharmacy under a patient-specific prescription. Before fulfillment, ask which pharmacy is assigned, who handles delivery problems and whether an order can still be stopped once the pharmacy receives it.
The products advertised are compounded injectable semaglutide and tirzepatide. MANÜ acknowledges that its compounded GLP-1 medications have not been evaluated by FDA for safety, quality or efficacy. FDA explains that compounded preparations are not FDA approved and recommends them when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not establish clinical inequivalence. FDA also explicitly advises not using an injectable GLP-1 that arrives warm or insufficiently refrigerated; contact the provider or dispensing pharmacy.
Define ongoing care beyond the renewal charge
MANÜ’s institutional page advertises continuous support, regular follow-up consultations, progress tracking and treatment-plan adjustments as needed. It also advertises 24/7 patient support. The consulted documentation does not specify consultation frequency or a response-time commitment. Those omissions matter for a recurring service: a payment schedule is not itself a clinical follow-up schedule, and an always-available contact channel does not establish when a clinician will review a concern.
The legal center explicitly warns that messages, forms, intake submissions and refill requests may not be reviewed immediately. It says the platform is not for emergencies, directing emergency users to 911 or an emergency department and U.S. suicide or mental-health crisis users to call or text 988. For routine care, ask who reviews symptoms, who authorizes refills and what to do if a refill request remains unanswered near the expected fulfillment date.
The privacy policy provides a route to request an electronic or paper copy of health information, usually within 30 days, with a possible reasonable, cost-based fee. That is relevant if care moves elsewhere. More broadly, NIDDK describes follow-up as attention to treatment response and tolerability, not merely renewed payments. MANÜ’s advertised check-ins are therefore worth clarifying in operational terms: who conducts them, how they occur and whether their cost is covered by the quoted package.
Questions & answers
Can I use MANÜ if I do not live in Florida?
The public documentation does not provide a dependable yes. The homepage advertises provider and pharmacy coverage in all 50 states, subject to address confirmation and network changes. The privacy policy instead restricts service to Florida residents and tells others not to use it. Ask MANÜ to resolve that conflict in writing for your state before proceeding with enrollment or payment.
What will my first semaglutide or tirzepatide charge be?
The consulted pages do not establish it. MANÜ advertises GLP-1s from $4 per day in one homepage block and from $5 per day in another, without explaining the difference. Neither supplies a complete product-specific billing schedule. Ask for the exact compounded injectable product, supply amount, first payment, renewal amount and billing interval. The FAQ says medication packages include consultation, medication, supplies and shipping.
How do I cancel a MANÜ clinical subscription?
The general terms direct cancellation requests to info@manutelehealth.com and say cancellation normally takes effect at the end of the current billing cycle. Partial billing periods are not refunded unless legally required. Request confirmation of the effective date and whether an order is already being fulfilled. The separate requirement for at least 48 hours’ notice is documented for nutrition-store subscriptions, not automatically for clinical subscriptions.
Will MANÜ refund me if treatment does not go ahead?
The answer depends on the documented circumstance. If MANÜ cancels an order after payment, its terms promise a full refund to the original payment method. Otherwise, the general rule is final sales, with stated exceptions, and generally no refund after services are rendered or medication dispensed. The pages do not clearly settle every declined-prescription situation. Obtain that answer before paying for clinical review or fulfillment.
Does MANÜ itself prepare and ship the medication?
MANÜ says it does not dispense, ship or distribute medication from its facility or website. It describes fulfillment exclusively through U.S. 503A pharmacies, and its privacy policy names Boudreaux, Shields Pharmacy and Hallandale as preparation and shipping participants. Ask which pharmacy will fill your prescription and which party handles shipment problems. Free shipping is advertised, but delivery timing and clinical-shipment replacement terms are not established.
Does 24/7 support mean immediate clinician access?
No immediate clinical response is established. MANÜ advertises 24/7 patient support, but the legal center warns that messages, forms and refill requests may not be reviewed immediately. It also says the platform is not an emergency service. Ask how routine treatment questions are routed, when a clinician responds and whether follow-up consultations are included in your specific package rather than assuming all support contacts have the same scope.
Our assessment
MANÜ documents a recognizable virtual-care offering: compounded injectable GLP-1 medications, clinical review, third-party pharmacy fulfillment and advertised follow-up. Its terms usefully disclose prescription discretion, recurring billing, cancellation by email and refunds for company-canceled paid orders. Yet the agreement is not sufficiently clear from public pages alone. Conflicting geographic restrictions, inconsistent descriptions of the clinical entity and incomplete medication prices are material enrollment issues. A prospective patient should obtain state-specific eligibility confirmation, a complete charge schedule, the responsible practice and pharmacy identities, and written cancellation and refund answers before authorizing payment. Those clarifications would improve contractual transparency; they would not establish clinical effectiveness or suitability for an individual.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- MANÜ Telehealth — en/start ↗
- MANÜ Telehealth — en/weight loss/semaglutide ↗
- MANÜ Telehealth — en/about ↗
- MANÜ Telehealth — en/weight loss/tirzepatide ↗
- MANÜ Telehealth — en ↗
- MANÜ Telehealth — en/patient legal ↗
- MANÜ Telehealth — en/weight loss/mic ultraburn ↗
- MANÜ Telehealth — en/privacy policy ↗
- MANÜ Telehealth — en/terms of service ↗